50 results on '"Bardoulat, I."'
Search Results
2. Étude comparative de l’utilisation des inhibiteurs de JAK et TNF initiés dans la polyarthrite rhumatoïde : données de vraie vie à partir d’une base de délivrances en pharmacie
3. Economic and disease burden of RSV-associated hospitalizations in young children in France, from 2010 through 2018
4. POS0312 A REAL-LIFE COMPARATIVE STUDY OF JAK INHIBITORS AND TNF INHIBITORS IN RHEUMATOID ARTHRITIS WITH DRUG DISPENSING DATA FROM RETAIL PHARMACIES IN FRANCE
5. RWD55 Immunosuppressive (IS) Treatment Patterns Following Kidney Transplant in France: A Real-World Retrospective Cohort Using the French National Health Data System (SNDS) Claim Databases Oister Study
6. Impact de la crise de COVID-19 sur les consultations pour troubles psychiques en médecine générale en France, en regard de consultations pour maladies chroniques – Analyse de séries temporelles
7. Utilisation de l'Echantillon généraliste des bénéficiaires (EGB) pour décrire les modalités de prescription des traitements Immunosuppresseurs (IS) chez les transplantés rénaux en France
8. Additional file 1 of Economic and disease burden of RSV-associated hospitalizations in young children in France, from 2010 through 2018
9. PRS19 Economic Burden of RSV Hospitalization of Children UNDER 5 YEARS Old in France between 2010 and 2018
10. Fardeau hospitalier du Virus respiratoire syncitial (VRS) chez l’enfant de moins de 5 ans entre 2010 et 2018 : utilisation des données du PMSI
11. Psoriasis: an epidemiological evaluation of disease burden in 590 patients
12. Étude FRANTALGIC – Intensification du traitement par opioïde chez les utilisateurs douloureux chroniques : analyse des données de remboursement de l’Assurance maladie
13. Télémédecine et dépenses de santé – une modélisation économique évaluant l’impact d’une intervention en télémédecine dans trois pathologies chroniques : diabète de type 2, hypertension artérielle et cancer de la prostate
14. EVODIA – Étude visant à démontrer l’« effectiveness » de la prise en charge par pompe à insuline et sa prestation d’accompagnement à domicile des patients diabétiques de type 1
15. Impact d’un traitement par un comprimé d’immunothérapie sublinguale aux pollens de 5 graminées sur la rhinite allergique aux pollens de graminées et l’évolution naturelle de l’asthme : analyse à long terme en vie réelle en France
16. Long-Term Impact of Grass-Pollen (GP) Sublingual Immunotherapy Tablet (SLIT) on Allergic Rhinitis (AR) and on Allergic Asthma (AA) Onset and Progression
17. L’observance médicamenteuse des patients diabétiques de type II en Île-de-France : état des lieux et priorités d’actions
18. Medical Cost Of Patients With Non-Valvular Atrial Fibrillation (Nvaf) And Treated With Vitamin K Antagonists (Vkas) According To Inr Control Status In Spain
19. A REAL-LIFE COMPARATIVE STUDY OF JAK INHIBITORS AND TNF INHIBITORS IN RHEUMATOID ARTHRITIS WITH DRUG DISPENSING DATA FROM RETAIL PHARMACIES IN FRANCE.
20. Patterns of use of oral anticancer treatments in France: a Retrospective Analysis of Cancer Treatments given ORally from 2004 to 2012 (Re-ACTOR study)
21. PRS2 - Long-Term Impact of Grass-Pollen (GP) Sublingual Immunotherapy Tablet (SLIT) on Allergic Rhinitis (AR) and on Allergic Asthma (AA) Onset and Progression
22. Management Costs of the First Five Years After Diagnosis in Breast Cancer by Stage in France
23. Current Situation of Oral Anticancer Treatments Use in France: The Actor Study (Analysis of Cancer Treatments Given Orally)
24. Evolution of Oral Anticancer Treatments Use in France from 2004 – 2012: Re-Actor Study (Retrospective Analysis of Cancer Treatments Given Orally)
25. PGI28 Gastroesophageal Reflux Disease: Impact on Work Productivity and Daily Life Activities of Daytime Workers. A French Cross Sectional Study (ACTA)
26. PCV67 - Medical Cost Of Patients With Non-Valvular Atrial Fibrillation (Nvaf) And Treated With Vitamin K Antagonists (Vkas) According To Inr Control Status In Spain
27. PHP75 The Cost Per Day of Intensive Care Units (ICU) in France: The CRRÉA Study
28. PSS39 PSORIASIS: AN EPIDEMIOLOGIC EVALUATION OF DISEASE BURDEN IN 590 PATIENTS
29. PMS62 INDIRECT COSTS OF RHEUMATOID ARTHRITIS AND THEIR DETERMINANTS
30. PMS87 IMPACT OF RHEUMATOID ARTHRITIS (RA) ON WORKING CONDITIONS AND INCOME
31. Patterns of use of oral anticancer treatments in France: a Retrospective Analysis of Cancer Treatments given ORally from 2004 to 2012 (Re-ACTOR study)
32. PCN185 - Evolution of Oral Anticancer Treatments Use in France from 2004 – 2012: Re-Actor Study (Retrospective Analysis of Cancer Treatments Given Orally)
33. PCN188 - Current Situation of Oral Anticancer Treatments Use in France: The Actor Study (Analysis of Cancer Treatments Given Orally)
34. PCN66 - Management Costs of the First Five Years After Diagnosis in Breast Cancer by Stage in France
35. PCV67 Medical Cost Of Patients With Non-Valvular Atrial Fibrillation (Nvaf) And Treated With Vitamin K Antagonists (Vkas) According To Inr Control Status In Spain
36. PCN66 Management Costs of the First Five Years After Diagnosis in Breast Cancer by Stage in France
37. PCN185 Evolution of Oral Anticancer Treatments Use in France from 2004 – 2012: Re-Actor Study (Retrospective Analysis of Cancer Treatments Given Orally)
38. Treatment Persistence and Switching Patterns of Adalimumab Biosimilar ABP 501 in European Patients with Rheumatologic Diseases.
39. Treatment persistence and switching patterns of ABP 501 in European patients with inflammatory bowel disease.
40. Treatment patterns in patients with rheumatoid arthritis initiating a JAK inhibitor or a TNF inhibitor based on retail pharmacies drug-dispensing data.
41. Trends and characteristics of attempted and completed suicides reported to general practitioners before vs during the COVID-19 pandemic in France: Data from a nationwide monitoring system, 2010-2022.
42. Effects of the COVID-19 pandemic on head lice and scabies infestation dynamics: a population-based study in France.
43. Common communicable diseases in the general population in France during the COVID-19 pandemic.
44. Immunotherapy with grass pollen tablets reduces medication dispensing for allergic rhinitis and asthma: A retrospective database study in France.
45. Do intra-articular hyaluronic acid injections delay total knee replacement in patients with osteoarthritis - A Cox model analysis.
46. EQOFIX: a combined economic and quality-of-life study of hemophilia B treatments in France.
47. The daily cost of ICU patients: A micro-costing study in 23 French Intensive Care Units.
48. Quality of Life in Patients Suffering from Active Exudative Age-Related Macular Degeneration: The EQUADE Study.
49. Gastroesophageal reflux disease: impact on work productivity and daily-life activities of daytime workers. A French cross-sectional study.
50. Daily costs of prostaglandin analogues as monotherapy or in fixed combinations with timolol, in Denmark, Finland, Germany and Sweden.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.